Regeneron Pharmaceuticals Inc. (REGN) Stock | Share Price | News
REGN · Health Care ·
United States
Regeneron Pharmaceuticals Inc. (REGN) is a company in the Health Care sector, based in United States. The stock is held in 22 ETFs we track – with its largest weight of 1.33 % in XUHC (msci-usa-health-care). That means you can hold Regeneron Pharmaceuticals indirectly and diversified through an ETF savings plan.
Very high ETF coverage: 22 of the 95 ETFs we cover hold Regeneron Pharmaceuticals, spread across 10 indices. That puts the stock in more ETFs than 90.0 % of the 4,369 stocks we cover.
Price chart
Performance
| Year to date | +2.3 % | 1 year | +37.0 % |
|---|---|---|---|
| 1 month | +14.2 % | 3 months | +29.2 % |
| Calendar year 2025 | +8.4 % | ||
| Calendar year 2026 | +2.9 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Amgen Inc. | +0.48 | |
| Bristol-Myers Squibb Company | +0.48 | |
| Vertex Pharmaceuticals Incorporated | +0.45 | |
| Royalty Pharma plc Class A | +0.43 | |
| Baxter International Inc. | +0.42 | |
| STERIS plc | +0.41 | |
| USD/JPY | -0.41 | |
| F5 Inc. | -0.34 | |
| USD/CHF | -0.27 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 13.1 | 4.0 | 30.1 % |
| FY2024 | 14.2 | 4.4 | 31.1 % |
| FY2025 | 14.3 | 4.5 | 31.4 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 1.33 % |
| XUHL | msci-usa-health-care | 1.33 % |
| SPFS | msci-world-health-care | 0.98 % |
| XDWH | msci-world-health-care | 0.98 % |
| EXXT | nasdaq-100 | 0.36 % |
| XNAS | nasdaq-100 | 0.36 % |
| XD9U | msci-usa | 0.13 % |
| XD9D | msci-usa | 0.13 % |
| XDEB | msci-world-minimum-volatility | 0.13 % |
| SXR8 | sp500 | 0.12 % |
| SPYL | sp500 | 0.12 % |
| SPY5 | sp500 | 0.12 % |
| EUNL | msci-world | 0.09 % |
| XDWD | msci-world | 0.09 % |
| SPPW | msci-world | 0.09 % |
| SPYI | msci-acwi-imi | 0.09 % |
| SPSA | msci-acwi-imi | 0.09 % |
| XDWL | msci-world | 0.09 % |
| SWWD | msci-world | 0.09 % |
| IUSQ | msci-acwi | 0.08 % |
| SPYY | msci-acwi | 0.08 % |
| WIMI | msci-world-imi | 0.08 % |
Want to know how much Regeneron Pharmaceuticals Inc. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Regeneron Pharmaceuticals — the figure counts the ETFs holding both.
Intuitive Surgical Inc.ISRG · 21 shared ETFs
Amgen Inc.AMGN · 22 shared ETFs · r +0.48
Vertex Pharmaceuticals IncorporatedVRTX · 22 shared ETFs · r +0.45
DexCom Inc.DXCM · 21 shared ETFs
AbbVie Inc.ABBV · 20 shared ETFs
Abbott LaboratoriesABT · 20 shared ETFs
Boston Scientific CorporationBSX · 20 shared ETFs
Cardinal Health Inc.CAH · 20 shared ETFs
Latest Investment Intelligence News: Stocks
· MixedThe week in markets: Russell 2000 lags the week (-1.4%) · August 24–28, 2026
· MixedRed across the board: only 20 of 90 assets hold gains – August 28, 2026
· Risk-onS&P 500 Informationstechnologie tops the major indices at +3.2% – August 27, 2026
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026